AHRQ Study On E-Prescribing Cost-Effectiveness Proposed In House Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
An Agency for Healthcare Research & Quality study would assess the ability of e-prescribing to reduce medical errors under legislation introduced by Rep. Bilirakis (R-Fla.). The bill heads to the House Energy & Commerce Committee after clearing the Health Subcommittee.
You may also be interested in...
Rx Controlled Substances Bills Head To President’s Desk
The bills would ease restrictions on exporting controlled substances and limitations on medical practices that treat drug-addicted patients.
Rx Controlled Substances Bills Head To President’s Desk
The bills would ease restrictions on exporting controlled substances and limitations on medical practices that treat drug-addicted patients.
E-Prescribing Draft Rule Proposes Adoption Of Formulary Info Standards
The proposal would establish standards for delivering formulary information based on an RxHub protocol. Under the rule, formulary transmissions would include information on coverage, preferred alternative drugs and comparative copayments.